Paloma Partners’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,682
| Closed | -$68.5K | – | 1102 |
|
|
2024
Q2 | $68.5K | Buy |
+3,682
| New | +$68.5K | ﹤0.01% | 704 |
|
|
2020
Q1 | – | Sell |
-12,436
| Closed | -$4.03M | – | 1557 |
|
|
2019
Q4 | $4.03M | Buy |
12,436
+4,936
| +66% | +$1.6M | 0.06% | 247 |
|
|
2019
Q3 | $2.05M | Buy |
+7,500
| New | +$2.05M | 0.04% | 306 |
|
|
2018
Q4 | – | Sell |
-1,968
| Closed | -$1.8M | – | 1275 |
|
|
2018
Q3 | $1.8M | Sell |
1,968
-25,719
| -93% | -$23.5M | 0.03% | 337 |
|
|
2018
Q2 | $20.3M | Buy |
27,687
+27,545
| +19,398% | +$20.2M | 0.37% | 24 |
|
|
2018
Q1 | $227K | Sell |
142
-725
| -84% | -$1.16M | ﹤0.01% | 1255 |
|
|
2017
Q4 | $777K | Buy |
+867
| New | +$777K | 0.01% | 626 |
|
|
2016
Q3 | – | Sell |
-1,041
| Closed | -$222K | – | 1541 |
|
|
2016
Q2 | $222K | Buy |
+1,041
| New | +$222K | ﹤0.01% | 1472 |
|
|
2015
Q3 | – | Sell |
-2,939
| Closed | -$551K | – | 1474 |
|
|
2015
Q2 | $551K | Buy |
+2,939
| New | +$551K | 0.01% | 840 |
|
|
2015
Q1 | – | Sell |
-1,006
| Closed | -$234K | – | 1223 |
|
|
2014
Q4 | $234K | Sell |
1,006
-994
| -50% | -$231K | 0.01% | 864 |
|
|
2014
Q3 | $362K | Buy |
+2,000
| New | +$362K | 0.02% | 591 |
|
|
2013
Q4 | – | Sell |
-667
| Closed | -$105K | – | 1125 |
|
|
2013
Q3 | $105K | Buy |
+667
| New | +$105K | ﹤0.01% | 831 |
|